Patents Assigned to Molecullar Rx, Inc.
  • Multiple sclerosis associated polypeptide
    Patent number: 5883227
    Abstract: The present invention relates to the diagnosis of multiple sclerosis. More specifically, this invention relates to an assay for detecting antigen(s) associated with multiple sclerosis. The present invention also relates to the generation of hybridomas which produce monoclonal antibodies which are specific for the multiple sclerosis-associated antigens. The present invention's use is in diagnosing multiple sclerosis and in routine follow-up monitoring of multiple sclerosis patients as to disease progression or response to therapy.
    Type: Grant
    Filed: October 28, 1996
    Date of Patent: March 16, 1999
    Assignees: Molecullar Rx, Inc., Cell Med, Inc.
    Inventors: Ellis L. Kline, Daniel H. Zimmerman